Verapamil (VP) improves the outcome after renal transplantation (CRT)

  • I. Dawidson
  • C. Lu
  • B. Palmer
  • P. Peters
  • P. Rooth
  • R. Risser
  • A. Sagalowsky
  • Z. Sandor
Conference paper

Abstract

Calcium antagonists (CATs) have a role in the management of certain types of renal insufficiency [6, 15]. These include prophylaxis against post-transplant-associated acute renal failure and cyclosporine A (CsA)-induced renal dysfunction. For the transplanted kidney, CATs may be beneficial in several settings. First, a CAT during organ procurement protects the kidney during ischemic periods [9]. Second, CATs given perioperatively protect the kidney during reperfusion and early after transplantation [2]. Third, CATs also offer protection against CsA nephrotoxicity [1].

Key words

Renal transplantation Verapamil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dawidson I, Rooth P, Fry W, San dor Z, Willms C, Coorpender L, Alway C, Reisch J (1989) Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil. Transplantation 48:575–580PubMedGoogle Scholar
  2. 2.
    Dawidson I, Rooth P, Lu C, Sagalowsky A, Diller K, Palmer B, Peters P, Risser R, Sandor Z, Seney F (1991) Verapamil improves the outcome after cadaver renal transplantation. JASN (in press)Google Scholar
  3. 3.
    Dy G, Raja R, Mendez M (1991) The clinical and biochemical effect of calcium channel blockers (CCB) in organ transplantation recipients (TR) on cyclosporine (CsA). Transplant Proc (in press)Google Scholar
  4. 4.
    Fry WR, Dawidson I, Alway CC, Rooth P (1988) Cyclosporine A induces decreased blood flow in cadaveric kidney transplant. Transplant Proc 20:222PubMedGoogle Scholar
  5. 5.
    Israelit A, Long D, White M, Hull A (1973) Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. Kidney Int 4:346PubMedCrossRefGoogle Scholar
  6. 6.
    Loutzenhiser R, Epstein M (1990) The renal hemodynamic effects of calcium antagonists. In: Epstein M (ed) Calcium antagonists and the kidney. Hanley & Belfus, Philadelphia, pp 33–73Google Scholar
  7. 7.
    McMillen MA, Lewis T, Jaffe B, Wait R (1985) Verapamil inhibition of lymphocyte proliferation and function in vitro. J Surg Res 39:76–80CrossRefGoogle Scholar
  8. 8.
    Neumayer H, Wagner K (1986) Diltiazem and economic use of cyclosporine. Lancet 1:523CrossRefGoogle Scholar
  9. 9.
    Neumayer HH, Wagner K (1987) Prevention of delayed graft function in cadaver kidney transplant by diltiazem: outcome of two prospective, randomized clinical trials. J Cardiovasc Pha-racol 10:170–177Google Scholar
  10. 10.
    Palmer B, Dawidson I, Sagalowsky A, Sandor Z, Lu C (1991) Calcium channel blockers improve the outcome of cadaveric renal transplantation. Transplantation (in press)Google Scholar
  11. 11.
    Prisch JD, Voss BJ, D’Alessandro AM, et al (1990) A controlled, double-blind, randomized trial of verapamil in cyclosporine -treated cadaver renal transplant patients. Abstract presented at the American Society of Transplant Physicians, 9th Annual Meeting, Chicago, May 29–30Google Scholar
  12. 12.
    Renton KW (1985) Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil. Biochem Pharmacol 34:2549–2553PubMedCrossRefGoogle Scholar
  13. 13.
    Rooth P, Dawidson I, Diller K, Taljedal IB (1988) Protection against cyclosporine-induced impairment of renal microcirculation by verapamil in mice. Transplantation 45:433–137PubMedCrossRefGoogle Scholar
  14. 14.
    Rooth P, Dawidson I, Clothier N, Diller K (1988) In vivo fluorescence microscopy of kidney subcapsular blood flow in mice; effects of cyclosporine A (CsA), Nva2) — Cyclosporine (CsG) and isradipine, a new calcium antagonist. Transplantation 46:566PubMedCrossRefGoogle Scholar
  15. 15.
    Schrier RW, Arnold ED, Van Putten V, Burke TJ (1987) Cellular calcium in ischemic acute renal failure: role of calcium entry blocker. Kidney Int 32:313–321PubMedCrossRefGoogle Scholar
  16. 16.
    Weir MR, Peppier R, Comolka D, Handwerger BS (1988) Additive effects of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells. Transplant Proc 20:240–244PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • I. Dawidson
    • 1
  • C. Lu
    • 1
  • B. Palmer
    • 1
  • P. Peters
    • 1
  • P. Rooth
    • 1
  • R. Risser
    • 1
  • A. Sagalowsky
    • 1
  • Z. Sandor
    • 1
  1. 1.U. T. Southwestern Med. Ctr.Parkland HospitalDallas, TexasUSA

Personalised recommendations